2022
DOI: 10.1007/s13204-021-02312-6
|View full text |Cite
|
Sign up to set email alerts
|

Engineering of combination drug delivery of pH/reduction response potential nanocarrier for the treatment of liver cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 58 publications
0
2
0
Order By: Relevance
“…The amphiphilic polymer mPEG-PLA efficiently encapsulates DOX and CAP to create the dual-drug loaded nanomaterials CAP/DOX@NPs, which release the medicines in response to acid and reduction stimuli. 120 According to the confocal laser scanning microscopy findings and flow cytometry, the co-loaded drug NPs were quickly absorbed by the HepG2 liver cancer cell and released intracellularly. This led to enhanced cell deaths and synergistic therapeutic effects from the co-loaded drug NP.…”
Section: Application In Cancer Treatmentmentioning
confidence: 99%
“…The amphiphilic polymer mPEG-PLA efficiently encapsulates DOX and CAP to create the dual-drug loaded nanomaterials CAP/DOX@NPs, which release the medicines in response to acid and reduction stimuli. 120 According to the confocal laser scanning microscopy findings and flow cytometry, the co-loaded drug NPs were quickly absorbed by the HepG2 liver cancer cell and released intracellularly. This led to enhanced cell deaths and synergistic therapeutic effects from the co-loaded drug NP.…”
Section: Application In Cancer Treatmentmentioning
confidence: 99%
“…(Figure 1) [72]. Yan et al used polyethylene glycol-based polymers (α-lipoic acid) and the mPEG-α-PLA copolymer to construct a double-reduction/pH response nanocarrier for capsaicin (CAP) and doxorubicin (DOX) [73]. Zeng et al designed a dual-drug-loading nanosystem (named a THCD NP) that could selectively transport and target tumor cells for the treatment of cancer [74].…”
Section: Research Progress On Dual-drug-delivery Nano-theranostic Age...mentioning
confidence: 99%